PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-2983

  1. 583 Posts.
    lightbulb Created with Sketch. 134
    Yes, in my mind I say it is 4-5 years to get to market from here. So I am thinking 2026 at a minimum. If I set my expectations low/realistic, then when we have the invariable delay or setback, it doesn't affect me as much.

    Of course we could have AA or another left-field announcement like a take-over but I don't rely on that.

    I find it also helpful to look at CSL's share price graph since listing. From the IPO in 1994, $10k has turned into $4.0mn according to Motley Fool.

    However you can clearly see periods like 2007-2012 where the share price did nothing for those 5 years. It also dropped about 75% in the early 2000's growth market shake-out, very similar to what is happening to unproven growth companies presently.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.035(12.7%)
Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.